Abstract
The Role of Hba1c in Severity and Mortality Rate of ST Segment Elevation Myocardial Infarction for Hospitalized Libyan Non-Diabetic Patients
Highlights
Patients with diabetes are at 3-4 times increased risk for cardiovascular mortality compared with non-diabetes [1]
In addition to the higher rate of acute ST- elevation myocardial infarction (STEMI) in diabetes, hyperglycemia is associated with poor prognosis in these patients [3]
There were some other studies supporting the association between admission serum HbA1c level and increased long-term mortality of non-diabetic patients admitted with STEMI and higher rate coronary artery disease (CAD) in these patients [5]
Summary
Patients with diabetes are at 3-4 times increased risk for cardiovascular mortality compared with non-diabetes [1]. In addition to the higher rate of acute ST- elevation myocardial infarction (STEMI) in diabetes, hyperglycemia is associated with poor prognosis in these patients [3]. Higher HbA1c level was associated with high cardiovascular disease and death [4]. There were some other studies supporting the association between admission serum HbA1c level and increased long-term mortality of non-diabetic patients admitted with STEMI and higher rate CAD in these patients [5]. We have evaluated the association of admission level of HbA1c with the hospital outcome of non-diabetic patient with STEMI. The severity of coronary artery disease (CAD) is directly related to the quality of glucose control in diabetic patient. Diabetes is associated with increased mortality following acute myocardial infarction compared to general population
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
